Computational oncology—mathematical modelling of drug regimens for precision medicine

D Barbolosi, J Ciccolini, B Lacarelle, F Barlési… - Nature reviews Clinical …, 2016 - nature.com
Computational oncology is a generic term that encompasses any form of computer-based
modelling relating to tumour biology and cancer therapy. Mathematical modelling can be …

Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect

G Bocci, RS Kerbel - Nature Reviews Clinical Oncology, 2016 - nature.com
Metronomic chemotherapy describes the close, regular administration of chemotherapy
drugs at less-toxic doses over prolonged periods of time. In 2015, the results of randomized …

Evidence for therapeutic drug monitoring of targeted anticancer therapies

B Gao, S Yeap, A Clements, B Balakrishnar… - Journal of Clinical …, 2012 - ascopubs.org
Therapeutic drug monitoring (TDM) provides valuable guidance for dose adjustment of
antibiotics, immunosuppressives, antiepileptics, and other drugs, but its use for traditional …

Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults

MP Pai - … : The Journal of Human Pharmacology and Drug …, 2012 - Wiley Online Library
The average weight of adults in the U nited S tates has increased by 25 pounds (11 kg) over
the past 50 years, with a marginal change in height. Drugs are generally dosed according to …

Closed-loop control of circulating drug levels in live animals

PL Mage, BS Ferguson, D Maliniak… - Nature Biomedical …, 2017 - nature.com
Current methods of drug dosing rely on physical parameters (such as sex, age and weight)
that do not account for genetic and physiological differences among individual patients …

Moving towards dose individualization of tyrosine kinase inhibitors

HJ Klümpen, CF Samer, RHJ Mathijssen… - Cancer treatment …, 2011 - Elsevier
Molecular targeted therapies with tyrosine kinase inhibitors (TKIs) have been a recent
breakthrough in cancer treatment. These small molecules are mainly used at a fixed dose …

Ultra-High-Precision, in-vivo Pharmacokinetic Measurements Highlight the Need for and a Route Toward More Highly Personalized Medicine

PA Vieira, CB Shin, N Arroyo-Currás… - Frontiers in Molecular …, 2019 - frontiersin.org
Clinical drug dosing would, ideally, be informed by high-precision, patient-specific data on
drug metabolism. The direct determination of patient-specific drug pharmacokinetics (“peaks …

Animal models and their role in imaging-assisted co-clinical trials

DM Peehl, CT Badea, TL Chenevert, HE Daldrup-Link… - Tomography, 2023 - mdpi.com
The availability of high-fidelity animal models for oncology research has grown enormously
in recent years, enabling preclinical studies relevant to prevention, diagnosis, and treatment …

Impact of outpatient interventions made at an ambulatory cancer centre oncology pharmacy in Singapore

C Chew, J Chiang, TT Yeoh - Journal of Oncology Pharmacy …, 2015 - journals.sagepub.com
Objectives To evaluate the clinical significance of interventions made by pharmacists in an
oncology pharmacy in Singapore and their acceptance rate and to identify common drug …

Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non‐Hodgkin's lymphoma

JS Pérez‐Blanco, D Santos‐Buelga… - British Journal of …, 2016 - Wiley Online Library
Aims The aims of the study were:(i) to characterize the pharmacokinetics (PK) of doxorubicin
(DOX) and doxorubicinol (DOXol) in patients diagnosed with non‐Hodgkin's lymphoma …